Premium
Hot Features
Inscrivez-vous pour interagir sur nos forums actifs pour discuter avec des investisseurs aux idées similaires.
Cue Biopharma Inc is a clinical-stage biopharmaceutical company. It is developing a novel and proprietary class of biologics drugs for the selective modulation of the human immune system to treat a broad range of cancers and autoimmune disorders. Its lead drug candidate comprises CUE-101, a variant ... Cue Biopharma Inc is a clinical-stage biopharmaceutical company. It is developing a novel and proprietary class of biologics drugs for the selective modulation of the human immune system to treat a broad range of cancers and autoimmune disorders. Its lead drug candidate comprises CUE-101, a variant form of the cytokine Interleukin-2 and a T cell antigen to target and activate T cells specific to HPV-related cancers. The other products under pipeline are CUE-102, CUE-103, CUE-400, and CUE-401. Show more
| Période | Variation | Variation % | Ouver. | Haut | Bas | Moyenne Vol. Quot. | VWAP | |
|---|---|---|---|---|---|---|---|---|
| 1 | -0.0573 | -6.82142857143 | 0.84 | 0.8849 | 0.72 | 272728 | 0.79099815 | CS |
| 4 | -0.2273 | -22.504950495 | 1.01 | 1.05 | 0.59 | 213353 | 0.76128105 | CS |
| 12 | -0.5973 | -43.2826086957 | 1.38 | 1.54 | 0.59 | 184004 | 1.04757228 | CS |
| 26 | -0.8973 | -53.4107142857 | 1.68 | 1.9891 | 0.59 | 348600 | 1.29239673 | CS |
| 52 | -0.7673 | -49.5032258065 | 1.55 | 2.26 | 0.45 | 426397 | 1.20137525 | CS |
| 156 | -3.6073 | -82.1708428246 | 4.39 | 5.12 | 0.45 | 330591 | 2.30579746 | CS |
| 260 | -21.2173 | -96.4422727273 | 22 | 35.5 | 0.45 | 337615 | 7.06455079 | CS |
Les dernières valeurs consultées apparaîtront dans cette boîte, vous permettant de choisir facilement les titres vus auparavant.
Assistance: support@advfn.fr
En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales
